Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers

Bibliographic Details
Main Authors:	Limin Zou, Yueli Qi, Yongling Jiang, Ling Tang, Yu Du, Boyuan Zhao, Yanzhe Sun, Meiyi Xiang, Jun Ma, Zhimin Yang
Format:	Article
Language:	English
Published:	Wiley 2023-02-01
Series:	Cancer Communications
Online Access:	https://doi.org/10.1002/cac2.12400

Internet

https://doi.org/10.1002/cac2.12400